HOW TRANSPARENT IS NH? FOLLOW OUR SCORECARD

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

35.34 -2.01 (-5.38%)
Delayed Quote Updated: 1:22 PM EST, Nov 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Stryker, Omnicell, Zimmer Biomet, Artivion, and Dentsply Sirona shares are soaring, what you need to know
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat... 
Via StockStory
News headline image
Omnicell’s Q3 earnings call: our top 5 analyst questions
Omnicell’s third quarter was marked by disciplined operational execution, which the market responded to positively. Management attributed performance to ongo... 
Via StockStory
Topics Earnings
News headline image
OMCL Q3 deep dive: disciplined cost control offsets flat sales, software transition in early innings
Healthcare tech company Omnicell (NASDAQ:OMCL) reported revenue ahead of Wall Street’s expectations in Q3 2026, but sales were flat year on year at $307.9 mi... 
Via StockStory
News headline image
Omnicell Q3 Earnings Call Highlights ↗
Omnicell (NASDAQ:OMCL) reported third-quarter 2026 revenue and non-GAAP EBITDA above the high end of its prior guidance, while executives said the company is preparing to begin shipments of its Titan... 
Via MarketBeat
Topics Earnings
Omnicell (NASDAQ:OMCL) Profit Beat and Raised Guidance Offset Soft Q4 Revenue Outlook ↗
Via Chartmill
Robotics Earnings Week: Momentum vs. Value as Four Automation Names Report ↗
Via Chartmill
News headline image
Omnicell (OMCL) Q3 2026 Earnings Call Transcript ↗
EPS surpassed guidance on cost discipline and favorable customer mix. 
Via The Motley Fool
Topics Earnings
News headline image
Omnicell (NASDAQ:OMCL) exceeds Q3 2026 expectations but quarterly revenue guidance misses expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) announced better-than-expected revenue in Q3 2026, but revenue was flat year on year at $307.9 million. On the... 
Via StockStory
News headline image
Omnicell Announces Third Quarter 2026 Financial Results
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell earnings: what to look for from OMCL
Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting earnings this Thursday before market hours. Here’s what to expect. Omnicell beat analysts’ r... 
Via StockStory
Topics Artificial Intelligence
Three Earnings Reports Put the Automation Rally to the Test ↗
Via Chartmill
Omnicell (NASDAQ:OMCL) Q2 Earnings Beat Overshadowed by Disappointing Guidance ↗
Via Chartmill
Topics Earnings
Nvidia, Teradyne, and Omnicell Earnings Set to Test Robotics Sector’s Divergent Momentum ↗
Via Chartmill
News headline image
3 Small-Cap Stocks We Approach with Caution
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
From Omnicell, Inc.
Via Business Wire
News headline image
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
Topics Economy
News headline image
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
Via StockStory
News headline image
3 Reasons OMCL is Risky and 1 Stock to Buy Instead
Omnicell has been treading water for the past six months, recording a small loss of 4.6% while holding steady at $32.74. The stock also fell short of the S&P... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Heavy Stock to Target This Week and 2 We Question
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o... 
Via StockStory
News headline image
1 Cash-Producing Stock on Our Buy List and 2 We Ignore
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
From Omnicell, Inc.
Via Business Wire
News headline image
3 Small-Cap Stocks We Approach with Caution
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
News headline image
Omnicell President Sells 6,753 Shares ↗
Nnamdi Njoku's disposal reduced his direct holdings by 4%, with over half tied to tax withholding from RSU vesting. He retains ~161,223 shares worth $5.81 million. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Q2 Earnings Call Highlights ↗
Omnicell (NASDAQ:OMCL) reported second-quarter 2026 revenue at the high end of its prior outlook and profitability above expectations, while widening its full-year product bookings range to reflect... 
Via MarketBeat
Topics Earnings World Trade
News headline image
Omnicell (OMCL) Stock Trades Down, Here Is Why
What Happened? Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 9.9% in the afternoon session after the company issued weak guidance for the upc... 
Via StockStory
Topics Artificial Intelligence
News headline image
Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance
Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.4% year on year to $312.2 million. On th... 
Via StockStory
News headline image
Omnicell Announces Second Quarter 2026 Financial Results
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell (OMCL) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what investors should know. Omnicell beat an... 
Via StockStory
News headline image
2 Cash-Heavy Stocks to Target This Week and 1 We Turn Down
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article